Senator expands opioid probe to more drug makers, wholesalers | Pharmaguy's Insights Into Drug Industry News |

Top Senate Democrat is expanding a probe into the opioid crisis by asking four more drug makers, as well as the nation’s largest pharmaceutical distributors, for a raft of information.

In a series of letters, U.S. Sen. Claire McCaskill (D-Mo.) wants the companies to explain the steps they have taken to mitigate the opioid epidemic, particularly monitoring suspicious orders and preventing the diversion of the prescription painkillers. The letters were sent to Teva Pharmaceuticals, Allergan, Endo International, and Mallinckrodt, along with Cardinal Health, McKesson, and AmerisourceBergen.

“We’ve seen numerous reports that potentially hundreds of millions of opioid pills wound up on the black market, fueling a nationwide epidemic,” McCaskill said in a statement.


We need a better understanding of how committed these companies are to preventing this type of drug diversion or whether they are turning a blind eye.